期刊文献+

冠心病合并2型糖尿病患者血清尿酸水平与经皮冠状动脉介入治疗术后再狭窄的关系 被引量:1

Relationship between serum uric acid level and post-PCI restenosis in coronary artery disease patients accompanied by type 2 diabetes mellitus
下载PDF
导出
摘要 目的 探讨冠心病合并 2型糖尿病患者血清尿酸 (UA)水平与经皮冠状动脉介入治疗 (PCI)术后再狭窄严重程度的相关性。方法 对 91例曾接受经皮冠状动脉腔内成形术 (PTCA)及支架置入术的冠心病合并 2型糖尿病患者测定血清UA及其他临床生化指标。根据 6个月后冠状动脉造影复查的结果 ,分为再狭窄组(37例 )和对照组 (5 4例 )进行回顾性分析。结果 再狭窄组的血清UA水平为 (495 .2 1± 10 3.5 5 )mmol/L ,明显高于对照组的 (434 .5 5± 94.6 2 )mmol/L(P <0 .0 0 1)。再狭窄组内的亚组分析显示 ,急性心肌梗死组和心绞痛组的血清UA水平分别为 (5 2 0 .18± 12 3.33)mmol/L和 (5 31.46± 91.72 )mmol/L ,均明显高于陈旧性心肌梗死组的 (44 1.92± 78.43)mmol/L(P值均 <0 .0 5 )。多因素逐步回归分析显示 ,冠心病合并 2型糖尿病患者支架内再狭窄程度积分与血清UA水平间存在显著线性回归关系 (P <0 .0 0 1)。结论 血清UA水平与冠心病合并 2型糖尿病患者PCI术后再狭窄程度密切相关。 Objective To investigate the correlation between serum uric acid level and post-PCI restenosis in coronary heart disease patients accompanied by type 2 diabetes mellitus.Methods The serum uric acid level and other clinical biochemical parameters were measured in 91 coronary artery disease patients accompanied by type 2 diabetes mellitus who had undergone percutaenous coronary interventions. According to the results after six-month follow-up,the data of 37 in the restenosis group and 54 in the control group were reviewed and analyzed retrospectively. Results The level of serum uric acid was significantly higher in the restenosis group than that in the control group [( 495.21 ±103.55) mmol/L vs ( 434.55 ±94.62) mmol/L, P <0.001]. Analysis of subgroups in the restenosis group also indicated that serum uric acid level was higher in recent acute myocardial infarction subgroup and angina pectoris subgroup than that in old myocardial infarction subgroup [( 520.18 ±123.33) mmol/L vs ( 441.92 ±78.43) mmol/L, P =0.027;( 531.46 ±91.72) mmol/L vs ( 441.92 ±78.43) mmol/L , P =0.011].Using stepwise regression analysis ,a linear regression relationship was found between serum levels of uric acid, blood glucose two hour after meal, total cholesterol and in-stent restenosis score in coronary artery disease patients with type 2 diabetes(P<0.001).Conclusion Serum uric acid level is strongly correlated with the degree of post-PCI restenosis in coronary heart disease patients accompanied by type 2 diabetes. Whether lowering of serum uric acid level can lead to alleviation of post- PCI restenosis remains to be revealed by further prospective study.
出处 《上海医学》 CAS CSCD 北大核心 2003年第9期648-650,共3页 Shanghai Medical Journal
关键词 冠心病 合并症 2型糖尿病 血清 尿酸水平 经皮冠状动脉介入治疗 术后 再狭窄 Coronary artery disease Diabetes mellitus Uric acid Restenosis
  • 相关文献

参考文献9

  • 1李丽,李南,白树功,郭路芬.急性心肌梗塞与血尿酸浓度关系探讨[J].心肺血管病杂志,1999,18(4):275-277. 被引量:23
  • 2胡健,沈卫峰,张建盛,张大东,张瑞岩,吕安康,张奇,张宪,郑爱芳.冠状动脉内支架置入术后再狭窄与尿酸的关系[J].临床心血管病杂志,2002,18(8):359-360. 被引量:38
  • 3Carrozza JP, Kurtz RE, Fishman RF, et al. Restenosis after arterial injury caused by coronary stenting in patients with diabetes mellitus. Ann Intern Med , 1993,118:344-349.
  • 4Fajadet JC, Marco J, Cassagneau BG, et al. Restenosis following successful palmaz-schatz intra coronary stent implantation. J Am Coil Cardiol, 1991,17(suppl) : A346.
  • 5Rathmann W, Hauner H, Dannehl K, et al. Association of devated serum uric acid with coronary heart disease in diabetes mellitus.Diabete Metab , 1993,19 : 159-166.
  • 6Mabuehi H, Koizumi J, Shimizu M, et al. Development of coronary heart disease in familial hypercholesterolemia. Circulation,1989, 79:225-232.
  • 7St Claire DA Jr, King SB 3rd. Effect of diabetes mellitus on outcome after percutaneous transluminal coronary angioplasty. Coron Artery Dis , 1996,7:744-752.
  • 8Freedman DS, Williamson DF, Gunter EW, et al. Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I Epidemiologic Follow-up Study. Am J Epidemiol,1995,141 : 637-644.
  • 9Wun YT, Chan CS, Lui CS, et al. Hyperuricaemia in Type 2 diabetes mellitus. Diabetes Nutr Metab, 1999,12: 286-291.

二级参考文献10

  • 1孙宜萍,吴松华,孙丽华,夏瑾玮,杨建芬,王懋瑛.胰岛素抵抗综合征中血尿酸水平及其影响因素探讨[J].上海医学,1996,19(5):269-271. 被引量:12
  • 2周北凡 吴锡桂.心血管病流行病学及人群防治[M].北京:人民出版社,1991.86-95.
  • 3Fischman D, Leon M,Bain D, et al.A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary disease. N Engl J Med, 1994,331:496-501.
  • 4Savage M P, Fischman D L, Rake R, et al. Efficacy of coronary stenting versus balloon angioplasty in small coronary arteries: Stent restenosis study[STRESS] investigators. J Am Coll Cardiol, 1998,31:307-311.
  • 5Kastrati S, Schomig A, Elezi S, et al. Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol, 1997,30:1428-1436.
  • 6Erbel R, Haude M, Hopp H W, et al. Restenosis stent(REST) study: Randomized trial comparing stenting and balloon angioplasty for treatment of restenosis after balloon angioplasty(abstract). J Am Coll Cardiol,1996,27(Suppl A):139-143.
  • 7Barbir M, Hunt B J, Galloway D, et al.A randomized pilot trial of low-dose combination lipid-lowering therapy following coronary artery bypass grafting. Clin Cardiol, 1994,17:59-65.
  • 8Loscalzo J, Weinfeld M, Fless G M, et al. Lipoprotein(a), fibrin binding and plasminogen activation. Arteriosclerosis,1990,10:240-245.
  • 9Fang J, Alderman M H. Serum uric acid and cardiovascular mortality. The NHANESI epidemiologic follow-up study, 1971-1992. JAMA, 2000,283:2404-2410.
  • 10郭静萱,毛节明,郭丽君,张福春,李海燕,温尚煜,赵一鸣,陈明哲.冠状动脉内支架再狭窄的多因素回归分析[J].中华心血管病杂志,1998,26(6):423-425. 被引量:33

共引文献59

同被引文献24

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部